48
Participants
Start Date
July 15, 2016
Primary Completion Date
December 17, 2018
Study Completion Date
June 13, 2019
Cipro (Ciprofloxacin, BAYQ3939)
Treatment parameters following the physician's decision based on the summary of product characteristics.
Multiple Locations
Lead Sponsor
Bayer
INDUSTRY